The ROE as of December 2025 (TTM) for Translational Development Acquisition Corp. (TDACU) is 3.77%

According to Translational Development Acquisition Corp.’s latest financial reports and current stock price. The company's current ROE is 3.77%. This represents a change of -162.34% compared to the average of -6.05% of the last 4 quarters.

Translational Development Acquisition Corp. (TDACU) Historical ROE (quarterly & annually)

How has TDACU ROE performed in the past?

The mean historical ROE of Translational Development Acquisition Corp. over the last ten years is 138.41%. The current 3.77% ROE has changed -97.27% with respect to the historical average. Over the past ten years (40 quarters), TDACU's ROE was at its highest in in the December 2023 quarter at 95.31%. The ROE was at its lowest in in the September 2025 quarter at -26.02%.

Translational Development Acquisition Corp. (TDACU) ROE by Quarter and Year

Discovering the peaks and valleys of Translational Development Acquisition Corp. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Translational Development Acquisition Corp. (TDACU) Average ROE

How has TDACU ROE performed in the past?

The current ROE of Translational Development Acquisition Corp. (TDACU) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Translational Development Acquisition Corp. (TDACU) ROE vs. Peers

How is TDACU’s ROE compared to its peers?

Translational Development Acquisition Corp.’s ROE is greater than dMY Squared Technology Group, Inc. (-254.85%), less than WinVest Acquisition Corp. (52.57%), less than Black Hawk Acquisition Corporation (4.02%), greater than FutureTech II Acquisition Corp. (-24.61%), less than Willow Lane Acquisition Corp. (2.73%), less than Horizon Space Acquisition I Corp. Ordinary Shares (8.84%), greater than Four Leaf Acquisition Corporation (-0.21%), greater than Welsbach Technology Metals Acquisition Corp. (-0.00%), less than Renatus Tactical Acquisition Corp I Class A Ordinary Shares (1.67%), greater than ESH Acquisition Corp. (-26.91%),

Build a custom stock screener for Translational Development Acquisition Corp. (TDACU) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Translational Development Acquisition Corp. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Translational Development Acquisition Corp. (TDACU) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Translational Development Acquisition Corp. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.